Ondansetron Hcl for Injection of Qilu was approved by USFDA

ABOUT US

图片名称

Ondansetron Hcl for Injection of Qilu was approved by USFDA


Release time:

2014-11-20

Ondansetron Hcl for Injection, manufactured by Qilu Pharmaceutical was approved by USFDA

 Recently, Ondansetron Hcl for Injection, manufactured by Qilu Pharmaceutical was approved by USFDA which means that it has been permitted to be sold in USA.

    As early as 1994, Qilu firstly launched Ondansetron Hcl in China. Since then, its market share has always maintained the leading position. Following after various FDFs and APIs of the company has been exported to EU, USA, Australia and many other countries, the approval is another significant breakthrough of FDF in US market. That means the capability of R&D, products manufacturing and quality control of Qilu has been highly recognized by international market.

齐鲁制药有限公司

Tel: +86-531-83127705831277048312770683127711

Address: 8888 Lvyou Road, High-tech Zone, Jinan, 250104, China

Email:export@qilu-pharma.com


监督举报

亲爱的合作伙伴:

欢迎举报以下行为!

索贿、暗箱操纵招标、内定中标单位、员工或亲属参与公司业务往来牟取私利、偷工减料、以次充好、故意刁难供应商等行为。

举报电话:0531-83126898/55820713/83126871

举报邮箱:qljc@qilu-pharma.com

收信地址:山东省济南市历城区旅游路8888号

齐鲁制药集团审计监察部

采购平台技术专线